| ENTA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ENTA shares outstanding history going back to 3/21/2013:
Also see: ENTA Market Cap History ENTA YTD Return |
ENTA Shares Outstanding History — Enanta Pharmaceuticals Share Count Over Time
As of 8/7/2026 Enanta Pharmaceuticals has 29.13 million ENTA shares outstanding. Investors often track the ENTA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ENTA share count trends over time, with 57 historical shares outstanding datapoints presented, dating back to 3/21/2013.
| ENTA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ENTA Historical Shares Outstanding: +4.18% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ENTA Stock Price Chart |
| About Enanta Pharmaceuticals Inc |
| Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on indications in virology and immunology. Co.'s research and development programs are focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU). Co. discovered glecaprevir, the second of two protease inhibitors discovered and developed through its collaboration with AbbVie for the treatment of chronic infection with hepatitis C virus (HCV). We show 57 historical shares outstanding datapoints in our coverage of ENTA's shares outstanding history. Understanding the changing numbers of ENTA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ENTA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ENTA by allowing them to research ENTA shares outstanding history as well as any other stock in our coverage universe. |
| ENTA Current Stock Quote |
Quotes delayed 20 minutes  Free ENTA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ENTA Share Performance |
| Shares Outstanding Peers |
| Enanta Pharmaceuticals (ENTA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ENTO Shares Outstanding History ENVB Shares Outstanding History ENZ Shares Outstanding History EOLS Shares Outstanding History EPZM Shares Outstanding History EQ Shares Outstanding History ERAS Shares Outstanding History ERNA Shares Outstanding History ESPR Shares Outstanding History ESRX Shares Outstanding History More Healthcare companies » |
ENTA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
